Value, Line

Value Line Announces Quarterly Dividend and Board Appointment

17.01.2026 - 10:32:06

Value Line US9204371002

Value Line, Inc., a provider of investment research and financial data, has outlined key corporate actions for its 2026 fiscal year. The company's board has declared its quarterly cash dividend and simultaneously filled a vacancy on its board of directors, moves that signal a commitment to governance continuity and shareholder returns.

Shareholders of Value Line common stock will receive a cash dividend of $0.325 per share for the first quarter of 2026. The payment is scheduled for distribution on February 10, 2026. To be eligible, investors must be on the company's shareholder register as of the record date, which is set for January 26, 2026.

Board of Directors Update

In a related governance development, the company has appointed Dr. Alexander J. Swistel to its board. He will also serve on the board's audit committee. This appointment fills the seat left by Alfred R. Fiore, who concluded a 15-year tenure on the board at the end of 2025.

Should investors sell immediately? Or is it worth buying Value Line?

Dr. Swistel brings an external perspective from outside the financial industry. He serves as an Associate Professor of Clinical Surgery and is an Attending Surgeon at the NewYork-Presbyterian/Weill Cornell Medical Center. His addition ensures the audit committee maintains its full complement of members, preserving its oversight function.

Financial and Market Position

Recent financial metrics highlight the firm's stable foundation:
* The company exhibits strong short-term liquidity, with a current ratio of 3.99.
* Its market capitalization stands at approximately $349.30 million.
* Ownership is highly concentrated, with insiders holding about 91.79% of shares.
* The limited number of shares available for public trading, a free float of just 752,940, suggests lower liquidity for individual investors.

Value Line shares recently traded at $37.26. The declaration of a consistent dividend, coupled with the prompt board appointment, reflects a strategy focused on steady operations. The robust liquidity position indicates the upcoming dividend payout is unlikely to strain the company's balance sheet. The next significant date for shareholders is the January 26 record date for the dividend.

Ad

Value Line Stock: Buy or Sell?! New Value Line Analysis from January 17 delivers the answer:

The latest Value Line figures speak for themselves: Urgent action needed for Value Line investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from January 17.

Value Line: Buy or sell? Read more here...

@ boerse-global.de | US9204371002 VALUE